Sign in

CIK 0000872589 · Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
133444607
Phone
9148477000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$51,901,544
in 11 filings, $8.6M under 10b5-1 plans

Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-08-23 Fenimore Christopher R. SVP Controller Option exercise · Non-Qualified Stock Option (right to buy) −7,000 10,000
2023-08-23 Landry Robert E EVP Finance CFO Sale −223 $844.00 $188K 31,699
2023-08-23 POON CHRISTINE A Director Option exercise +12,280 $273.67 $3.4M 14,317
2023-08-23 POON CHRISTINE A Director Sale −300 $837.92 $251K 14,017
2023-08-23 POON CHRISTINE A Director Sale −1,998 $838.60 $1.7M 12,019
2023-08-23 POON CHRISTINE A Director Sale −3,032 $839.45 $2.5M 8,987
2023-08-23 POON CHRISTINE A Director Sale −6,450 $840.65 $5.4M 2,537
2023-08-23 POON CHRISTINE A Director Sale −500 $841.05 $421K 2,037
2023-08-23 POON CHRISTINE A Director Option exercise · Non-Qualified Stock Option (right to buy) −12,280 0
2023-08-23 Van Plew Daniel P EVP & General Mgr, Industrial Option exercise +23,125 $381.40 $8.8M 44,633
2023-08-23 Van Plew Daniel P EVP & General Mgr, Industrial Shares withheld for taxes −16,928 $842.66 $14.3M 27,705
2023-08-23 Van Plew Daniel P EVP & General Mgr, Industrial Option exercise · Non-Qualified Stock Option (right to buy) −23,125 23,125
2023-08-22 STAHL NEIL EVP Research and Development Sale −6,309 $840.53 $5.3M 58,456
2023-08-22 STAHL NEIL EVP Research and Development Sale −4,574 $841.41 $3.8M 53,882
2023-08-22 STAHL NEIL EVP Research and Development Sale −782 $842.16 $659K 53,100
2023-08-21 STAHL NEIL EVP Research and Development Option exercise +50,000 $399.66 $20.0M 103,100
2023-08-21 STAHL NEIL EVP Research and Development Shares withheld for taxes −38,335 $833.39 $31.9M 64,765
2023-08-21 STAHL NEIL EVP Research and Development Option exercise · Non-Qualified Stock Option (right to buy) −50,000 30,750
2023-08-21 Bassler Bonnie L Director Option exercise 10b5-1 +853 $391.92 $334K 2,100
2023-08-21 Bassler Bonnie L Director Sale 10b5-1 −853 $829.00 $707K 1,247

Page 50 of 105 · 2,088 trades